OR WAIT null SECS
Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.
February 05, 2010
Capsules that can release their contents at a selected temperature have been developed by researchers in France, and could lead to the development of therapeutic agents that are applied to the skin and triggered locally by rubbing.
A highly functioning New Product Planning (NPP) group is a company's first line of defence against losses caused by products that fail to reach the market, according to research and consulting firm Best Practices LLC.
February 01, 2010
Pharmaceutical Technology Europe discusses some of the latest challenges and innovations that are expected to define the future of pharma.
January 29, 2010
Two US senators have introduced the Nanotechnology Safety Act of 2010, which would establish a programme within the FDA to assess the health and safety implications of nanotechnology in everyday products.
The Director General of the European Generic medicines Association (EGA) has reiterated the association?s Vision 2015 plan, which aims to create a globally competitive generic industry, increase patient access to affordable quality medicines and ensure sustainable healthcare in Europe.
The EMA has launched a public consultation on its Road Map to 2015 — a strategic vision that lays out the agency's priorities for the next 5 years.